Exonics Therapeutics' Seed VC Round

Exonics Therapeutics raised a round of funding on February 27, 2017. Investors include CureDuchenne Ventures.

Exonics Therapeutics is a biotechnology company focusing on utilizing gene editing technologies like CRISPR/Cas9 to advance the development of a treatment for Duchenne muscular dystrophy. Exonics' CRI…

Articles about Exonics Therapeutics' Seed VC Round: